“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about MapLight Therapeutics, Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS)
| C-Level 4 | VP - Level7 |
| Director23 | Manager13 |
| Others28 | |
| Pain Points | Locations | Technologies |
|---|---|---|
| Application Development | United States | communication, database, testing, risk, data quality, integrity, compliance, data management, collaboration, operations |
| Build & Release | United States | communication, database, testing, risk, data quality, integrity, compliance, data management, collaboration, operations |
| Compliance | Burlington, MA | quality assurance, communication, e, audit, compliance, scheduling, operations |
| Compliance | United States | communication, database, testing, risk, data quality, integrity, compliance, data management, collaboration, operations |
| Database Administration | United States | communication, database, testing, risk, data quality, integrity, compliance, data management, collaboration, operations |
MapLight Therapeutics, Inc looking to hire in Application Development in United States
MapLight Therapeutics, Inc looking to hire in Application Development in New Territories, Hong Kong SAR
MapLight Therapeutics, Inc looking to hire in Application Development in Riverbank, CA
Gcp
Netsuite
Access
Air
Board
Analytics
Archival
Archiving
Audit
Cgmp
Who We Are: MapLight Therapeutics is a clinical stage biotech company that focuses on drug discov...
View MoreWho We Are: MapLight Therapeutics is a clinical stage biotech company that focuses on drug discov...
View MoreInvesting.com -- MapLight Therapeutics (NASDAQ:MPLT) began trading on Nasdaq Global Market Monday at $19 per share, exceeding its initial public offering
Read MoreInvesting.com -- MapLight Therapeutics (NASDAQ:MPLT) began trading on Nasdaq Global Market Monday at $19 per share, exceeding its initial public offering
Read More(Updated - October 20, 2025 10:53 AM EDT). MapLight Therapeutics Inc.'s (MPLT) Nasdaq IPO has attracted orders exceeding the available shares ahead of its
Read MoreMapLight Therapeutics Inc.'s (MPLT) Nasdaq IPO has attracted orders exceeding the available shares ahead of its scheduled pricing on October 26,
Read MoreMaplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS)
Maplight therapeutics, inc operates in the Biotechnology research industry.
Maplight therapeutics, inc's revenue is $2.10m
Maplight therapeutics, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.